Skip to content

Free cash flow at other companies

Microsoft logo
MicrosoftMSFT
$15.8B-22.1%
IQVIA logo
IQVIAIQV
$491M+15.3%
Clarivate logo
ClarivateCLVT
$78.9M-28.5%
Health Catalyst logo
Health CatalystHCAT
$18.17M+4,760%
Teladoc Health logo
Teladoc HealthTDOC
$7.86M-40.5%
Claritev Corporation logo
Claritev CorporationCTEV
-$92.55M-34.3%

Other financials

Income statement

See full
Revenue$55.9M-5.5%
Gross profit$46.6M-5.0%
Operating income-$201.3M-8.9%
Net income-$138.6M-29.3%
EPS (diluted)-$1.32-38.9%

Balance sheet

See full
Cash & equivalents$157.6M+48.6%
Total debt$169.8M-6.0%
Total assets$514.7M-36.3%

Cash flow

See full
Operating cash flow$11.6M-55.6%
CapEx$3.2M-58.4%

Valuation

See full
Market cap$87.68M-78.4%
Enterprise value$99.87M-80.2%
P/S0.4×-1.3×

Profitability

See full
Gross margin84.4%+1.0pp
Operating margin-101.1%-42.1pp
Net margin-71.5%-28.2pp
FCF margin12.1%-8.4pp

Returns & leverage

See full
Current ratio1.8×0.0×

Where this comes from

Calculated from Definitive Healthcare Corp.’s reported figures.

The official record: Definitive Healthcare Corp.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Definitive Healthcare Corp.'s free cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Definitive Healthcare Corp.'s free cash flow?
Definitive Healthcare Corp. (DH) reported free cash flow of $8.36M in Q1 2026.
How has Definitive Healthcare Corp.'s free cash flow changed year-over-year?
Definitive Healthcare Corp.'s free cash flow decreased by 54.5% year-over-year, from $18.36M to $8.36M.
What is the long-term trend for Definitive Healthcare Corp.'s free cash flow?
Over 3 years (2021 to 2025), Definitive Healthcare Corp.'s free cash flow has grown at a 25.0% compound annual growth rate (CAGR), from $19.87M to $38.78M.
What does free cash flow mean?
Free cash flow represents the cash generated by a company after accounting for cash outflows to support operations and maintain or expand its capital asset base. It serves as a critical indicator of a company's ability to fund organic growth, pay down debt, or return capital to shareholders without relying on external financing.